Interestingly, by performing ChIP assays with antibodies directed against BMAL1, we found that BMAL1 binding to the E-box of PER2 was significantly decreased in obesity (Fig. 2B) while NF-κB binding was increased (Fig. 2A). The gene discussed is NFKB1; the disease is obesity disorder.